Defect in the p53-Mdm2 Autoregulatory Loop Resulting from Inactivation of TAF_II250 in Cell Cycle Mutant tsBN462 Cells

REFERENCES

• Argentin, M., Barboule N., and Wasylyk B.. The contribution of the RING finger domain of Mdm2 to cell cycle progression. Oncogene, in press.
   Google Scholar
• Attardi, L. D., and Jacks, T.. 1999. The role of p53 in tumour suppression: lessons from mouse models. Cell. Mol. Life Sci. 55:48–63
   PubMed Web of Science ®Google Scholar
• Bates, S., and Vousden, K. H.. 1999. Mechanisms of p53-mediated apoptosis. Cell. Mol. Life Sci. 55:28–37
   PubMed Web of Science ®Google Scholar
• Burley, S. K., and Roeder, R. G.. 1996. Biochemistry and structural biology of transcription factor IID (TFIID). Annu. Rev. Biochem. 65:769–799
   PubMed Web of Science ®Google Scholar
• Chang, K. W., Laconi, S., Mangold, K. A., Hubchak, S., and Scarpelli, D. G.. 1995. Multiple genetic alterations in hamster pancreatic ductal adenocarcinomas. Cancer Res. 55:2560–2568
   PubMed Web of Science ®Google Scholar
• Chen, C., and Okayama, H.. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2745–2752
   PubMed Web of Science ®Google Scholar
• Church, G. M., and Gilbert, W.. 1984. Genomic sequencing. Proc. Natl. Acad. Sci. USA 81:1991–1995
   PubMed Web of Science ®Google Scholar
• Conseiller, E., Debussche, L., Landais, D., Venot, C., Maratrat, M., Sierra, V., Tocque, B., and Bracco, L.. 1998. CTS1: a p53-derived chimeric tumor suppressor gene with enhanced in vitro apoptotic properties. J. Clin. Investig. 101:120–127
   PubMed Web of Science ®Google Scholar
• DeGregori, J., Kowalik, T., and Nevins, J. R.. 1995. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol. Cell. Biol. 15:4215–4224 (Erratum, 15:5846–5847.)
   PubMed Web of Science ®Google Scholar
• Dimri, G. P., Nakanishi, M., Desprez, P. Y., Smith, J. R., and Campisi, J.. 1996. Inhibition of E2F activity by the cyclin-dependent protein kinase inhibitor p21 in cells expressing or lacking a functional retinoblastoma protein. Mol. Cell. Biol. 16:2987–2997
   PubMedGoogle Scholar
• Dubs-Poterszman, M. C., Tocque, B., and Wasylyk, B.. 1995. MDM2 transformation in the absence of p53 and abrogation of the p107 G1 cell-cycle arrest. Oncogene 11:2445–2449
   PubMed Web of Science ®Google Scholar
• Dyson, N.. 1998. The regulation of E2F by pRB-family proteins. Genes Dev. 12:2245–2262
   PubMed Web of Science ®Google Scholar
• el-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B.. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817–825
   PubMed Web of Science ®Google Scholar
• Freedman, D. A., Epstein, C. B., Roth, J. C., and Levine, A. J.. 1997. A genetic approach to mapping the p53 binding site in the MDM2 protein. Mol. Med. 3:248–259
   PubMed Web of Science ®Google Scholar
• Freedman, D. A., Wu, L., and Levine, A. J.. 1999. Functions of the MDM2 oncoprotein. Cell. Mol. Life Sci. 55:96–107
   PubMed Web of Science ®Google Scholar
• Funk, W. D., Pak, D. T., Karas, R. H., Wright, W. E., and Shay, J. W.. 1992. A transcriptionally active DNA-binding site for human p53 protein complexes. Mol. Cell. Biol. 12:2866–2871
   PubMed Web of Science ®Google Scholar
• Haines, D. S.. 1997. The mdm2 proto-oncogene. Leuk Lymphoma 26:227–238
   PubMed Web of Science ®Google Scholar
• Hayashida, T., Sekiguchi, T., Noguchi, E., Sunamoto, H., Ohba, T., and Nishimoto, T.. 1994. The CCG1/TAFII250 gene is mutated in thermosensitive G1 mutants of the BHK21 cell line derived from golden hamster. Gene 141:267–270
   PubMedGoogle Scholar
• Helin, K.. 1998. Regulation of cell proliferation by the E2F transcription factors. Curr. Opin. Genet. Dev. 8:28–35
   PubMedGoogle Scholar
• Henglein, B., Chenivesse, X., Wang, J., Eick, D., and Brechot, C.. 1994. Structure and cell cycle-regulated transcription of the human cyclin A gene. Proc. Natl. Acad. Sci. USA 91:5490–5494
   PubMed Web of Science ®Google Scholar
• Herber, B., Truss, M., Beato, M., and Muller, R.. 1994. Inducible regulatory elements in the human cyclin D1 promoter. Oncogene 9:1295–1304 (Erratum, 9:2105–2107.)
   PubMed Web of Science ®Google Scholar
• Hinds, P. W., Finlay, C. A., Quartin, R. S., Baker, S. J., Fearon, E. R., Vogelstein, B., and Levine, A. J.. 1990. Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the “hot spot” mutant phenotypes. Cell Growth Differ. 1:571–580
   PubMedGoogle Scholar
• Honda, R., and Yasuda, H.. 1999. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J. 18:22–27
   PubMed Web of Science ®Google Scholar
• Hsieh, J. K., Chan, F. S., O'Connor, D. J., Mittnacht, S., Zhong, S., and Lu, X.. 1999. RB regulates the stability and the apoptotic function of p53 via MDM2. Mol. Cell 3:181–193
   PubMed Web of Science ®Google Scholar
• Hupp, T. R.. 1999. Regulation of p53 protein function through alterations in protein-folding pathways. Cell. Mol. Life Sci. 55:88–95
   PubMed Web of Science ®Google Scholar
• Janus, F., Albrechtsen, N., Dornreiter, I., Wiesmuller, L., Grosse, F., and Deppert, W.. 1999. The dual role model for p53 in maintaining genomic integrity. Cell. Mol. Life Sci. 55:12–27
   PubMed Web of Science ®Google Scholar
• Jayaraman, L., and Prives, C.. 1999. Covalent and noncovalent modifiers of the p53 protein. Cell. Mol. Life Sci. 55:76–87
   PubMed Web of Science ®Google Scholar
• Jones, S. N., Roe, A. E., Donehower, L. A., and Bradley, A.. 1995. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 378:206–208
   PubMed Web of Science ®Google Scholar
• Juven, T., Barak, Y., Zauberman, A., George, D. L., and Oren, M.. 1993. Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene. Oncogene 8:3411–3416
   PubMed Web of Science ®Google Scholar
• Kern, S. E., Pietenpol, J. A., Thiagalingam, S., Seymour, A., Kinzler, K. W., and Vogelstein, B.. 1992. Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 256:827–830
   PubMed Web of Science ®Google Scholar
• Kubbutat, M. H., Ludwig, R. L., Levine, A. J., and Vousden, K. H.. 1999. Analysis of the degradation function of Mdm2. Cell Growth Differ. 10:87–92
   PubMedGoogle Scholar
• La Thangue, N. B., Thimmappaya, B., and Rigby, P. W.. 1990. The embryonal carcinoma stem cell Ela-like activity involves a differentiation-regulated transcription factor. Nucleic Acids Res. 18:2929–2938
   PubMedGoogle Scholar
• Lee, C. W., Sorensen, T. S., Shikama, N., and La Thangue, N. B.. 1998. Functional interplay between p53 and E2F through co-activator p300. Oncogene 16:2695–2710
   PubMedGoogle Scholar
• Leveillard, T., and Wasylyk, B.. 1997. The MDM2 C-terminal region binds to TAFII250 and is required for MDM2 regulation of the cyclin A promoter. J. Biol. Chem. 272:30651–30661
   PubMed Web of Science ®Google Scholar
• Liu, H. T., Gibson, C. W., Hirschhorn, R. R., Rittling, S., Baserga, R., and Mercer, W. E.. 1985. Expression of thymidine kinase and dihydrofolate reductase genes in mammalian ts mutants of the cell cycle. J. Biol. Chem. 260:3269–3274
   PubMedGoogle Scholar
• Liu, N., Lucibello, F. C., Korner, K., Wolfraim, L. A., Zwicker, J., and Muller, R.. 1997. CDF-1, a novel E2F-unrelated factor, interacts with cell cycle-regulated repressor elements in multiple promoters. Nucleic Acids Res. 25:4915–4920
   PubMedGoogle Scholar
• Liu, N., Lucibello, F. C., Zwicker, J., Engeland, K., and Muller, R.. 1996. Cell cycle-regulated repression of B-myb transcription: cooperation of an E2F site with a contiguous corepressor element. Nucleic Acids Res. 24:2905–2910
   PubMed Web of Science ®Google Scholar
• Martin, K., Trouche, D., Hagemeier, C., Sorensen, T. S., La Thangue, N. B., and Kouzarides, T.. 1995. Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein. Nature 375:691–694
   PubMed Web of Science ®Google Scholar
• Medema, R. H., Wubbolts, R., and Bos, J. L.. 1991. Two dominant inhibitory mutants of p21ras interfere with insulin-induced gene expression. Mol. Cell. Biol. 11:5963–5967
   PubMed Web of Science ®Google Scholar
• Momand, J., and Zambetti, G. P.. 1997. Mdm-2: “big brother” of p53. J. Cell. Biochem. 64:343–352
   PubMed Web of Science ®Google Scholar
• Montes de Oca Luna, R., Wagner, D. S., and Lozano, G.. 1995. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378:203–206
   PubMed Web of Science ®Google Scholar
• Nishimoto, T., Sekiguchi, T., Kai, R., Yamashita, K., Takahashi, T., and Sekiguchi, M.. 1982. Large-scale selection and analysis of temperature-sensitive mutants for cell reproduction from BHK cells. Somatic Cell Genet. 8:811–824
   PubMedGoogle Scholar
• O'Brien, T., and Tjian, R.. 1998. Functional analysis of the human TAFII250 N-terminal kinase domain. Mol. Cell 1:905–911
   PubMedGoogle Scholar
• O'Connor, D. J., Lam, E. W., Griffin, S., Zhong, S., Leighton, L. C., Burbidge, S. A., and Lu, X.. 1995. Physical and functional interactions between p53 and cell cycle co-operating transcription factors, E2F1 and DP1. EMBO J. 14:6184–6192
   PubMedGoogle Scholar
• Oren, M., and Rotter, V.. 1999. Introduction: p53--the first twenty years. Cell. Mol. Life Sci. 55:9–11
   PubMed Web of Science ®Google Scholar
• Philips, A., Huet, X., Plet, A., Le Cam, L., Vie, A., and Blanchard, J. M.. 1998. The retinoblastoma protein is essential for cyclin A repression in quiescent cells. Oncogene 16:1373–1381
   PubMed Web of Science ®Google Scholar
• Piette, J., Neel, H., and Marechal, V.. 1997. Mdm2: keeping p53 under control. Oncogene 15:1001–1010
   PubMed Web of Science ®Google Scholar
• Rushton, J. J., Steinman, R. A., and Robbins, P. D.. 1997. Differential regulation of transcription of p21 and cyclin D1 conferred by TAF(II)250. Cell Growth Differ. 8:1099–1104
   PubMedGoogle Scholar
• Schulze, A., Zerfass, K., Spitkovsky, D., Middendorp, S., Berges, J., Helin, K., Jansen-Durr, P., and Henglein, B.. 1995. Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site. Proc. Natl. Acad. Sci. USA 92:11264–11268
   PubMed Web of Science ®Google Scholar
• Sekiguchi, T., Nakashima, T., Hayashida, T., Kuraoka, A., Hashimoto, S., Tsuchida, N., Shibata, Y., Hunter, T., and Nishimoto, T.. 1995. Apoptosis is induced in BHK cells by the tsBN462/13 mutation in the CCG1/TAFII250 subunit of the TFIID basal transcription factor. Exp. Cell Res. 218:490–498
   PubMedGoogle Scholar
• Sekiguchi, T., Nishimoto, T., and Hunter, T.. 1999. Overexpression of D-type cyclins, E2F-1, SV40 large T antigen and HPV16 E7 rescue cell cycle arrest of tsBN462 cells caused by the CCG1/TAF(II)250 mutation. Oncogene 18:1797–1806
   PubMedGoogle Scholar
• Sekiguchi, T., Noguchi, E., Hayashida, T., Nakashima, T., Toyoshima, H., Nishimoto, T., and Hunter, T.. 1996. D-type cyclin expression is decreased and p21 and p27 CDK inhibitor expression is increased when tsBN462 CCG1/TAFII250 mutant cells arrest in G1 at the restrictive temperature. Genes Cells 1:687–705
   PubMedGoogle Scholar
• Sekiguchi, T., Yoshida, M. C., Sekiguchi, M., and Nishimoto, T.. 1987. Isolation of a human X chromosome-linked gene essential for progression from G1 to S phase of the cell cycle. Exp. Cell Res. 169:395–407
   PubMedGoogle Scholar
• Sellers, W. R., Rodgers, J. W., Kaelin, W. G.Jr.. 1995. A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites. Proc. Natl. Acad. Sci. USA 92:11544–11548
   PubMed Web of Science ®Google Scholar
• Shen, W. C., and Green, M. R.. 1997. Yeast TAF(II)145 functions as a core promoter selectivity factor, not a general coactivator. Cell 90:615–624
   PubMed Web of Science ®Google Scholar
• Sorensen, T. S., Girling, R., Lee, C. W., Gannon, J., Bandara, L. R., and La Thangue, N. B.. 1996. Functional interaction between DP-1 and p53. Mol. Cell. Biol. 16:5888–5895
   PubMedGoogle Scholar
• Suzuki-Yagawa, Y., Guermah, M., and Roeder, R. G.. 1997. The ts13 mutation in the TAF(II)250 subunit (CCG1) of TFIID directly affects transcription of D-type cyclin genes in cells arrested in G1 at the nonpermissive temperature. Mol. Cell. Biol. 17:3284–3294
   PubMedGoogle Scholar
• Thomas, A., and White, E.. 1998. Suppression of the p300-dependent mdm2 negative-feedback loop induces the p53 apoptotic function. Genes Dev. 12:1975–1985
   PubMedGoogle Scholar
• Treisman, R.. 1995. Journey to the surface of the cell: Fos regulation and the SRE. EMBO J 14:4905–4913
   PubMedGoogle Scholar
• Walker, S. S., Shen, W. C., Reese, J. C., Apone, L. M., and Green, M. R.. 1997. Yeast TAF(II)145 required for transcription of G1/S cyclin genes and regulated by the cellular growth state. Cell 90:607–614
   PubMedGoogle Scholar
• Wallace-Brodeur, R. R., and Lowe, S. W.. 1999. Clinical implications of p53 mutations. Cell. Mol. Life Sci. 55:64–75
   PubMed Web of Science ®Google Scholar
• Wang, E. H., and Tjian, R.. 1994. Promoter-selective transcriptional defect in cell cycle mutant ts13 rescued by hTAFII250. Science 263:811–814
   PubMedGoogle Scholar
• Wang, E. H., Zou, S., and Tjian, R.. 1997. TAFII250-dependent transcription of cyclin A is directed by ATF activator proteins. Genes Dev. 11:2658–2669
   PubMedGoogle Scholar
• Wasylyk, C., Salvi, R., Argentini, M., Dureuil, C., Delumeau, I., Abecassis, J., Debussche, L., and Wasylyk, B.. 1999. p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53. Oncogene 18:1921–1934
   PubMed Web of Science ®Google Scholar
• Xiao, Z. X., Chen, J., Levine, A. J., Modjtahedi, N., Xing, J., Sellers, W. R., and Livingston, D. M.. 1995. Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature 375:694–698
   PubMed Web of Science ®Google Scholar
• Zerfass, K., Spitkovsky, D., Schulze, A., Joswig, S., Henglein, B., and Jansen-Durr, P.. 1996. Adenovirus E1A activates cyclin A gene transcription in the absence of growth factors through interaction with p107. J. Virol. 70:2637–2642
   PubMedGoogle Scholar
• Zhang, Y., Xiong, Y., and Yarbrough, W. G.. 1998. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92:725–734
   PubMed Web of Science ®Google Scholar
• Zwicker, J., Lucibello, F. C., Wolfraim, L. A., Gross, C., Truss, M., Engeland, K., and Muller, R.. 1995. Cell cycle regulation of the cyclin A, cdc25C and cdc2 genes is based on a common mechanism of transcriptional repression. EMBO J. 14:4514–4522
   PubMed Web of Science ®Google Scholar
• Zwicker, J., and Muller, R.. 1997. Cell-cycle regulation of gene expression by transcriptional repression. Trends Genet. 13:3–6
   PubMedGoogle Scholar